Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism SIK2 inhibitors(Serine/threonine-protein kinase SIK2 inhibitors), TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus | Discovery | - | 04 Apr 2025 | |
| Digestive System Disorders | Discovery | - | 04 Apr 2025 | |
| Immune System Diseases | Discovery | - | 04 Apr 2025 | |
| Neoplasms | Discovery | - | 04 Apr 2025 | |
| Nervous System Diseases | Discovery | - | 04 Apr 2025 | |
| Other Diseases | Discovery | - | 04 Apr 2025 | |
| Pulmonary Disease, Chronic Obstructive | Discovery | - | 04 Apr 2025 | |
| Skin and Musculoskeletal Diseases | Discovery | - | 04 Apr 2025 |





